The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells

SIMPLE SUMMARY: Aberrant alternative splicing is now considered a hallmark of cancer, including breast cancer. This results in the production of novel tumor-specific splice RNA variants, and the activation of biological processes such as epithelial-to-mesenchymal transition, leading to more aggressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhasnaoui, Jamal, Ferrero, Giulio, Miano, Valentina, Cutrupi, Santina, De Bortoli, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699117/
https://www.ncbi.nlm.nih.gov/pubmed/34944881
http://dx.doi.org/10.3390/cancers13246261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699117/
https://www.ncbi.nlm.nih.gov/pubmed/34944881
http://dx.doi.org/10.3390/cancers13246261

Ejemplares similares